CO4700479A1 - Agentes antifungicos de peptidos ciclicos - Google Patents

Agentes antifungicos de peptidos ciclicos

Info

Publication number
CO4700479A1
CO4700479A1 CO96026496A CO96026496A CO4700479A1 CO 4700479 A1 CO4700479 A1 CO 4700479A1 CO 96026496 A CO96026496 A CO 96026496A CO 96026496 A CO96026496 A CO 96026496A CO 4700479 A1 CO4700479 A1 CO 4700479A1
Authority
CO
Colombia
Prior art keywords
antifungal agents
cyclic peptide
peptide antifungal
parasiary
fungic
Prior art date
Application number
CO96026496A
Other languages
English (en)
Inventor
James Andrew Jamison
Michael John Rodriguez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO4700479A1 publication Critical patent/CO4700479A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PROPORCIONAN FORMULACIONES FARMACEUTICAS Y ME- TODOS PARA INHIBIR LA ACTIVIDAD FUNGICA Y PARASI- TARIA UTILIZANDO UN COMPUESTOS DE LA FORMULA I FIGURA 1 EN LA QUE: R, R", R" ", ...
CO96026496A 1995-05-26 1996-05-24 Agentes antifungicos de peptidos ciclicos CO4700479A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45305095A 1995-05-26 1995-05-26

Publications (1)

Publication Number Publication Date
CO4700479A1 true CO4700479A1 (es) 1998-12-29

Family

ID=23799012

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96026496A CO4700479A1 (es) 1995-05-26 1996-05-24 Agentes antifungicos de peptidos ciclicos

Country Status (13)

Country Link
US (1) US5618787A (es)
EP (1) EP0744404B1 (es)
JP (1) JPH11505847A (es)
AT (1) ATE233786T1 (es)
AU (1) AU5799496A (es)
CA (1) CA2220944A1 (es)
CO (1) CO4700479A1 (es)
DE (1) DE69626439T2 (es)
ES (1) ES2188722T3 (es)
IL (1) IL118333A0 (es)
PE (1) PE38697A1 (es)
WO (1) WO1996037512A1 (es)
ZA (1) ZA964013B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6146872A (en) * 1996-06-13 2000-11-14 Fukisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
WO2000011023A2 (en) 1998-08-20 2000-03-02 Eli Lilly And Company Ring modified cyclic peptide analogs
WO2000034315A2 (en) 1998-12-09 2000-06-15 Eli Lilly And Company Purification of echinocandin cyclopeptide compounds
AU776782C (en) * 1999-03-03 2005-04-07 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
RU2001126723A (ru) * 1999-03-03 2003-09-27 Эли Лилли энд Компани (US) Эхинокандин/углеводные комплексы
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
ES2270819T3 (es) 1999-03-03 2007-04-16 Eli Lilly And Company Formacion e intercambio anionico de sales de amonio internas cristalinas de equinocandina.
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
EP1874724A2 (en) * 2005-04-22 2008-01-09 Merck & Co., Inc. Phenyl ethyne compounds
US8064666B2 (en) * 2007-04-10 2011-11-22 Avantis Medical Systems, Inc. Method and device for examining or imaging an interior surface of a cavity

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5233023A (en) * 1991-07-30 1993-08-03 Merck & Co., Inc. Process for phosphate ester compounds of certain cyclohexapeptides
IL105048A (en) * 1992-03-19 2001-06-14 Eli Lilly And Company U S Antifungal substances of the cyclic peptide type and a process for their preparation

Also Published As

Publication number Publication date
DE69626439D1 (de) 2003-04-10
PE38697A1 (es) 1997-10-09
CA2220944A1 (en) 1996-11-28
US5618787A (en) 1997-04-08
WO1996037512A1 (en) 1996-11-28
EP0744404A3 (en) 1998-05-20
AU5799496A (en) 1996-12-11
ZA964013B (en) 1997-11-20
IL118333A0 (en) 1996-09-12
ES2188722T3 (es) 2003-07-01
ATE233786T1 (de) 2003-03-15
JPH11505847A (ja) 1999-05-25
EP0744404A2 (en) 1996-11-27
DE69626439T2 (de) 2003-10-02
EP0744404B1 (en) 2003-03-05

Similar Documents

Publication Publication Date Title
KR950701911A (ko) 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient)
MX9803604A (es) Composiciones topicas para regular la apariencia grasosa/brillosa de la piel.
SE9504661D0 (sv) New compounds
GEP20012578B (en) (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
DE59711477D1 (de) Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
CO4700479A1 (es) Agentes antifungicos de peptidos ciclicos
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
FR2526271B1 (fr) Composition herbicide contenant un derive de 1, 2, 4-triazole a titre d'ingredient actif
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
ITRM920383A1 (it) Preparati liposomici contenenti un composto allilamminico come agente farmacologicamente attivo
NL192304B (nl) Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat.
FR2761885B1 (fr) Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ATE470434T1 (de) Thimerosal-freie konservierungsmittel für impfstoffe
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
FI945164A0 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
SE9504662D0 (sv) New compounds
DK0437225T3 (da) Topiske præparater
AR006860A1 (es) Mezclas fungicidas sinergicas, util para combatir hongos fitopatogenos y su procedimiento de aplicacion
EP0791350A3 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren
PT837677E (pt) Derivados hexa-hidroxibifenilo bromados